MSMEs underscore indispensability of compressed air for drug quality

INDIAN Pharma MSMEs are increasingly highlighting the critical role of compressed air systems in maintaining drug quality, safety, and manufacturing efficiency.

- Nandita Vijayasimha, Bengaluru

In the wake of the December 31, 2025 deadline for revised Schedule M compliance, many MSMEs are under pressure to upgrade infrastructure and adopt stringent quality control measures, especially in utilities such as compressed air, which is often treated as a peripheral element. According to Deepesh Upadhyay, assistant vice president, Delair India, the government is pledging to demonstrate zero tolerance towards substandard drugs, and complying with revised Schedule M in alignment with Good Manufacturing Practices has become mandatory for the pharma industry. In this pursuit of promoting production of safe, effective, and superior-quality drugs, industry players should conform to strict hygiene standards outlined by the FDA.